跳至主要内容
临床试验/ACTRN12615000559516
ACTRN12615000559516已完成3 期

Combined effects of Curcumin and Omega 3 fatty acids on plasma glucose, lipid levels and inflammation bio-markers in the individuals with pre-diabetes.

niversity of Newcastle0 个研究点目标入组 80 人开始时间: 2015年5月29日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
30 Years 至 70 Years(—)
性别
All

入选标准

  • Age – 30-70; gender – both males and females
  • No participation in any clinical trial for at least 3 months
  • An HbA1c of 5.7% - 6.4%
  • Impaired Glucose Tolerance (IGT):
  • 2-hour OGTT plasma glucose greater than or equal to 7.8 mmol/ Land <11.1 mmol/L
  • Impaired fasting glucose (IFG):
  • Fasting plasma venous glucose measurement 6.1–6.9 mmol/L
  • 12 or more score or High risk individuals in AUSDRISK assessment tool
  • BMI between 25-45

排除标准

  • Pregnancy or lactation
  • Established type 2 diabetes
  • Allergic to sea foods
  • People with gall bladder problems
  • People currently on medication with erythropoietin
  • People with anaemia
  • People with pace maker implants
  • Currently on medication with Aspirin and Warfarin
  • History of severe neurological diseases or seizures
  • History of new investigational drug three months prior to this trial
  • Consuming more than 2 serve of oily fish per week
  • Taking regular dietary supplements known to influence blood glucose level
  • People taking regular vitamin C supplements
  • Unwilling to fast for 10hr before obtaining blood samplePeople currently on medication with clopidogrel, ibuprofen, naproxen, dalteparin, enoxaparin and heparin,

研究者

发起方
niversity of Newcastle

相似试验